The Centralized List annual renewal application and fee must be submitted to DOJ by January 31st of each year regardless of the date of initial placement on the Centralized List. The Centralized List portion of the annual fee is $20.00 per licensee at each dealership.
Hydrocodone Bitartrate, USP 7.5 mg. Ibuprofen, USP 200 mg. VICOPROFEN (hydrocodone and ibuprofen) is supplied in a fixed combination tablet form for oral administration. VICOPROFEN (hydrocodone and ibuprofen) combines the opioid analgesic agent, hydrocodone bitartrate, with the nonsteroidal anti-inflammatory (NSAID) agent, ibuprofen.
Download Drug Summary (PDF) Information Regarding Carisoprodol Prescriptions. On December 12, 2011, DEA published a Final Rule (76 FR 77330) in the Federal Register making carisoprodol a schedule IV controlled substance. The Final Rule states that effective January 11, 2012, all prescriptions for drugs containing carisoprodol shall comply with 21 C.F.R. Â§Â§ 1306.03â1306.06, 1306.21, and 1306.22â1306.27.